Generali Investments Management Co LLC Purchases 5,873 Shares of CVS Health Corporation $CVS

Generali Investments Management Co LLC lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 117.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,854 shares of the pharmacy operator’s stock after purchasing an additional 5,873 shares during the period. Generali Investments Management Co LLC’s holdings in CVS Health were worth $748,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Bell Investment Advisors Inc increased its position in CVS Health by 55.6% during the second quarter. Bell Investment Advisors Inc now owns 708 shares of the pharmacy operator’s stock worth $49,000 after buying an additional 253 shares during the last quarter. Beta Wealth Group Inc. boosted its stake in shares of CVS Health by 1.3% during the 2nd quarter. Beta Wealth Group Inc. now owns 38,315 shares of the pharmacy operator’s stock worth $2,643,000 after acquiring an additional 487 shares during the period. Cornerstone Advisors LLC increased its holdings in shares of CVS Health by 15.4% during the 2nd quarter. Cornerstone Advisors LLC now owns 33,800 shares of the pharmacy operator’s stock worth $2,332,000 after acquiring an additional 4,500 shares during the last quarter. Citizens Financial Group Inc. RI raised its stake in CVS Health by 1.9% in the 2nd quarter. Citizens Financial Group Inc. RI now owns 24,390 shares of the pharmacy operator’s stock valued at $1,682,000 after acquiring an additional 455 shares during the period. Finally, Cercano Management LLC bought a new position in CVS Health during the second quarter worth $233,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of a number of research reports. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Morgan Stanley increased their price target on shares of CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a report on Tuesday, October 14th. Wells Fargo & Company reduced their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday. Cantor Fitzgerald increased their target price on CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Finally, Jefferies Financial Group boosted their price target on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.41.

CVS Health Stock Down 1.7%

CVS stock opened at $77.86 on Friday. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15. The business has a 50-day simple moving average of $77.70 and a 200 day simple moving average of $69.93. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The company has a market cap of $98.84 billion, a PE ratio of 204.90, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the firm earned $1.09 EPS. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s dividend payout ratio is presently 700.00%.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.